Drugs were produced by NECC in unsterile condition

It is widely discussed about the meningitis outbreak which has occurred in several states of America. Contaminated Methylprednisolone Acetate injections caused fungal meningitis in more than 500 patients. The contamination turned out to be fatal for 39 patients: they died. The majority of deaths took place in Tennessee.
It was noticed that contaminated steroid injections had been produced by the New England Compounding Center (NECC) that is based in Massachusetts. The FDA tested the pharmacy in order to set what led to contamination and see the situation at the NECC. It was confirmed by the FDA that the contaminated steroid injections were really produced by this company.
The FDA told the Associated Press that it was evident that manufacture of drugs was unsterile at the NECC. The FDA claimed that leaking water and uncontrolled temperature were only several problems at the compounding center. The equipment utilized for preparing of solution for injections was unsterile.
Furthermore, the FDA stated that there were certain other contaminants. Certain bacterial contaminants were discovered at the NECC. Although these contaminants were not real pathogens, they could lead to infection as well. These bacterial contaminants were found in such medications, as Betamethasone and Triamcinolone. There were not any situations reported about contamination resulted from intake of these products. But it was noted that these drugs were also capable to lead to contamination. Although the bacterial contaminants presented anywhere in the environment, they had not to be in preparations. This fact pointed at unsterile conditions at the pharmacy and affirmed that the Methylprednisolone Acetate injections turned out to be contaminated with fungal meningitis because they were prepared in inappropriate conditions.
The situation made it clear that new rules on pharmacies should be implemented. Contamination should be avoided. Otherwise, public health is in danger in the USA.